<DOC>
	<DOCNO>NCT00730444</DOCNO>
	<brief_summary>GE Healthcare recently submit New Drug Application ( NDA ) Iobenguane I 123 Injection ( [ 123I ] mIBG ( AdreView ) ) diagnostic nuclear imaging agent detection primary metastatic neuroblastoma pheochromocytoma . The present protocol establishes Expanded Access program provide AdreView pediatric medical center hospital treat neuroblastoma patient . AdreView provide use diagnostic assessment patient know suspected neuroblastoma appropriate clinical indication [ 123I ] mIBG imaging .</brief_summary>
	<brief_title>Expanded Access Protocol 123ImIBG Patients With Known Suspected Neuroblastoma</brief_title>
	<detailed_description>The sponsor provide [ 123I ] mIBG single dose ready-to-use vial . All patient great equal 18 year age child weight great equal 70 kg receive intravenous injection 370 ±10 % MBq ( 333 407 MBq [ 9.0 11 mCi ] ) [ 123I ] mIBG . Children &lt; 16 year age ( weight 8-70 kg ) receive activity [ 123I ] mIBG calculate basis reference activity adult scale body weight . Each investigator responsible obtain appropriate thyroid blockade agent administration accordance national local regulation guideline . Approximately 24 ( ± 6 ) hour follow administration [ 123I ] mIBG patient return clinic scintigraphic imaging . Imaging perform per standard procedure investigational site . This include minimum total body planar scintigraphy . Single photon emission compute tomography ( SPECT ) may perform follow planar scintigraphy , appropriate .</detailed_description>
	<mesh_term>Neuroblastoma</mesh_term>
	<mesh_term>3-Iodobenzylguanidine</mesh_term>
	<criteria>The patient know suspected neuroblastoma undergoing evaluation disease status ( mIBG scintigraphic examination clinically appropriate ) . The patient able willing comply study procedure sign date informed consent obtain patient ( legal guardian . The patient us medication know interfere [ 123I ] mIBG uptake medication safely withhold least 24 hour study procedure .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>Neuroblastoma</keyword>
	<keyword>Nuclear medicine</keyword>
	<keyword>Diagnostic scintigraphy</keyword>
	<keyword>Known suspect neuroblastoma</keyword>
</DOC>